U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Drugs
  3. News & Events for Human Drugs
  4. Global IDMP Implementation - Getting Closer to the Goal - 10/16/2024
  1. News & Events for Human Drugs

Virtual | Virtual

Event Title
Global IDMP Implementation - Getting Closer to the Goal
October 16, 2024

Date:
October 16, 2024
Time:
1:00 p.m. - 2:30 p.m. ET

Visit CDER Small Business and Industry Assistance Page

ABOUT THIS EVENT (Hosted by CDER SBIA)

Identification of Medicinal Products (IDMP) offers a global framework for the unique identification and consistent documentation of medicinal products, facilitating effective information exchange among regulators, manufacturers, suppliers, and distributors. Once fully adopted, these standards will enhance pharmacovigilance, address drug shortages, and improve medication safety worldwide.

This webinar will present an overview of the end-to-end testing results for the Global Pharmaceutical Product Identification (PhPID) Service operating model, which generates global PhPIDs for marketed medicinal products. The session will detail the model's readiness for deployment, including its software functionality, interoperability, processes, and business rules. Additionally, results from simulated real-world scenarios across three global IDMP use cases—Pharmacovigilance, Drug Shortages, and Cross-border Healthcare—will be discussed.

INTENDED AUDIENCE

  • Regulatory affairs professionals, international regulators and industry working on data standards, pharmacovigilance, product labelling, drug shortages, and electronic regulatory submissions
  • Consultants focused on data standards, pharmacovigilance, product labelling, and electronic regulatory submissions
  • IT professionals involved with the electronic exchange of medicinal product information

TOPICS

  • Introduction to IDMP Standards:
    • Overview of IDMP framework and its objectives
    • Importance of unique identification and consistent documentation for medicinal products
  • Global PhPID Service Operating Model:
    • Overview of the end-to-end testing project
    • Generation of global PhPIDs for marketed medicinal products
    • Readiness for deployment: software functionality, interoperability, processes, and business rules
  • Real-World Scenarios and Use Cases:
    • Results from simulated scenarios for:
      • Pharmacovigilance: Enhancing drug safety monitoring
      • Drug Shortages: Addressing supply chain challenges
      • Cross-border Healthcare: Facilitating international healthcare

FDA SPEAKERS

Ron Fitzmartin, PhD, MBA
Sr. Advisor
Data Standards Branch
Office of Regulatory Operations
Center for Biologics Evaluation and Research

Ta-Jen Chen
Project Management Officer
Office of Strategic Programs
Center for Drug Evaluation and Research

OTHER SPEAKERS

Olof Lagerlund, PhD
Substance Expert
Uppsala Monitoring Centre
WHO Collaborating Centre for International Drug Monitoring

FDA RESOURCES

Back to Top